# What to compare before choosing knee care *Knee Injections Peoria — Compare Care for Soreness* > Knee injections peoria compared in plain words, from home care and cortisone shots to gel, PRP and surgery alternatives. Begin with care that eases soreness while keeping the knee moving through your day. Exercise, a brace, and medicine may be enough for some knees. When they aren't enough, a shot may ease soreness for a time before surgery. These choices don't work alike, so the lowest price won't tell you enough. ## What to try before a knee procedure Keep the knee moving as much as feels reasonable, then trim the chore that sets it off. You may find that two short walks cause less swelling than one long outing. A brace or anti-inflammatory medicine can help some people, but medicine isn't harmless. Your doctor can tell you whether it suits your other health needs. ## What to know about gel injections for knee soreness A gel shot puts hyaluronic acid, a thick liquid meant to act like joint fluid, into your knee. Gel may take longer than cortisone to ease soreness, may require several visits, and doesn't help every knee enough to notice. If you're asking how long do cortisone shots last, the honest answer is that relief differs. Among the cortisone shot side effects, blood sugar may run high briefly, so tell the clinician about diabetes. ## What to ask about PRP and surgery alternatives For PRP, short for platelet-rich plasma, the clinic draws your blood and spins it so a small amount holds more platelets. QC Kinetix provides regenerative treatments for knee soreness, its name for non-surgical choices that include this blood-based care. Results are mixed, and a higher cash price doesn't prove you'll get more relief. Before paying for several visits, ask when you'll check walking, sleep, and soreness after the first one. ## Sources 1. The 2015 Cochrane review of 27 trials (1,767 participants) found intra-articular corticosteroid better than sham for knee OA pain (SMD -0.40, 95% CI -0.58 to -0.22; NNTB 8), but the benefit decayed with time: moderate at 1-2 weeks, small at 13 weeks, and no evidence of any effect at 26 weeks. All outcomes were graded LOW quality. Jüni P, et al. — [Intra-articular corticosteroid for knee osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/26490760/). *Cochrane Database Syst Rev*, 2015. DOI: 10.1002/14651858.CD005328.pub3. 2. In a 2-year double-blind RCT of 140 patients with symptomatic knee OA and ultrasound synovitis, 40 mg intra-articular triamcinolone every 12 weeks produced significantly greater cartilage volume loss than saline (index compartment cartilage thickness change -0.21 mm vs -0.10 mm; between-group difference -0.11 mm, 95% CI -0.20 to -0.03) with no significant difference in knee pain. McAlindon TE, et al. — [Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/28510679/). *JAMA*, 2017. DOI: 10.1001/jama.2017.5283. 3. A 2022 BMJ systematic review and meta-analysis of 169 trials (21,163 participants) found viscosupplementation produced only a small pain reduction versus placebo (SMD -0.08, 95% CI -0.15 to -0.02; about -2.0 mm on a 100 mm VAS), below the minimal clinically important difference, and trial sequential analysis indicated conclusive evidence of clinical equivalence with placebo since 2009. Pereira TV, et al. — [Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/36333100/). *BMJ*, 2022. DOI: 10.1136/bmj-2022-069722. 4. The RESTORE randomized trial (288 participants, leukocyte-poor PRP, 3 weekly injections) found no significant difference from saline placebo at 12 months in knee pain (-2.1 vs -1.8 points; difference -0.4, 95% CI -0.9 to 0.2) or in medial tibial cartilage volume (-1.4% vs -1.2%), with 29 of 31 secondary outcomes also showing no between-group difference. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 5. The 2019 ACR/Arthritis Foundation OA guideline makes a STRONG recommendation for intra-articular glucocorticoid injection in knee OA, alongside strong recommendations for exercise, weight loss, self-management, tai chi, cane use, bracing and NSAIDs; intra-articular steroid injection for HAND OA is only conditionally recommended. Kolasinski SL, et al. — [2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.](https://pubmed.ncbi.nlm.nih.gov/31908163/). *Arthritis Rheumatol*, 2020. DOI: 10.1002/art.41142. 6. The 2025 Cochrane living review of stem cell injections for knee OA (25 trials, 1,341 participants) found stem cell injection MAY slightly improve pain and function up to six months versus placebo (pain 1.2 points better on a 0-10 scale; function 14.2 points better on 0-100), but rated the evidence LOW certainty for both, downgraded for indirectness and suspected publication bias, with up to three larger RCTs withdrawn before reporting results. Whittle SL, et al. — [Stem cell injections for osteoarthritis of the knee.](https://pubmed.ncbi.nlm.nih.gov/40169165/). *Cochrane Database Syst Rev*, 2025. DOI: 10.1002/14651858.CD013342.pub2. 7. FDA's HCT/P guidance sets out the minimal-manipulation and homologous-use criteria that decide whether a human cell or tissue product is regulated solely under 21 CFR Part 1271 (section 361) or requires a biologics licence; cell-based orthopaedic injections that fall outside those criteria are unapproved drugs and biological products, and no cell-based product is FDA-approved to treat osteoarthritis. U.S. Food and Drug Administration — [Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use - Guidance for Industry and FDA Staff](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal). *U.S. Food and Drug Administration*, 2020. 8. A systematic review of eight studies (299 knees, mean follow-up 12.9 months) found BMAC improved 34 of 36 patient-reported outcomes from baseline, but all three comparative studies failed to show BMAC superior to other biologic injections or to placebo - a finding the authors weigh against its high cost. Keeling LE, et al. — [Bone Marrow Aspirate Concentrate for the Treatment of Knee Osteoarthritis: A Systematic Review.](https://pubmed.ncbi.nlm.nih.gov/34236913/). *Am J Sports Med*, 2022. DOI: 10.1177/03635465211018837. 9. An analysis of 37 randomized PRP trials found no significant difference in qualitative conclusions or outcome scores between industry-affiliated and non-industry-affiliated studies; overall, 19 of 37 (51.4%) reported PRP as favourable and 18 (48.6%) found no difference from comparators. Ta CN, et al. — [The Influence of Industry Affiliation on Randomized Controlled Trials of Platelet-Rich Plasma for Knee Osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/36594496/). *Am J Sports Med*, 2023. DOI: 10.1177/03635465221140917. 10. A study using fluoroscopy as the reference standard confirmed that injectate placed into the suprapatellar recess under ultrasound guidance disperses into the tibiofemoral joint after a brief bout of walking, and that blinded radiologist review corroborated the interventionalist's reading of correct needle placement. Varlotta C, et al. — [Accuracy of ultrasound-guided knee injections confirmed by fluoroscopy.](https://pubmed.ncbi.nlm.nih.gov/39239616/). *Interv Pain Med*, 2023. DOI: 10.1016/j.inpm.2022.100174. 11. A systematic review and meta-analysis of 32 trials classified PRP by total deliverable platelets and found all dose bands beat hyaluronic acid, with the moderate-dose band (5-10 billion platelets) showing the largest effect (SMD 1.48) and the low (1-5 billion) and high (>10 billion) bands moderate effects (SMD 0.47 and 0.68) — evidence that dose, not brand, drives reported differences. PM&R authors — [Platelet-rich plasma outcomes in knee osteoarthritis are associated with the amount of total deliverable platelets: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/40980837/). *PM&R*, 2026. DOI: 10.1002/pmrj.13455. ## What to ask before you decide At its Peoria office, QC Kinetix's medical providers—the clinicians who review your knee and handle the procedure—can explain regenerative treatments, meaning non-surgical care such as PRP, or platelet-rich plasma, prepared from blood the clinic draws and concentrates. The word regenerative doesn't promise that a knee part will grow back. Ask how many visits are planned and what the whole amount includes. Take your medicine list and notes about when the soreness began. You can also take an X-ray and ask about driving afterward. A visit isn't a promise that any choice will suit your knee. The office is at 13128 N. 94th Dr., Suite 205, by Thunderbird Road and Loop 101. Its phone number is (602) 837-PAIN. You'll know the cost and visit count before choosing. Book a free consultation: --- Know what you're paying for before you agree to care. Plain help for knee soreness in Peoria, including home care, warning signs, treatment choices, costs and the nearby QC Kinetix office. Plain help with knee soreness, care choices, costs and driving in Peoria. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Peoria location it recommends; it is first-party educational and marketing content from a business that benefits when readers book. © 2026 The Peoria Knee Ledger. General education only; it is not medical advice, a diagnosis, an insurer decision or a personal price quote.